TB-500 calculators

This hub gathers the four TB-500 calculators in one place — reconstitution, dose, mg ↔ units, and vial duration — pre-filled with a 5 mg / 2 mL example so the math is concrete the moment the page loads. TB-500 sits in the Healing category, and the numbers each tool surfaces are tuned to how people actually log this peptide: 2 shots a week at the 2 mg example dose. A synthetic fragment of Thymosin Beta-4 studied for its role in cellular actin dynamics and cell migration.

At the example concentration of 2.5 mg/mL, a 2 mg TB-500 dose draws roughly 80 units on a U-100 insulin syringe — the Dose calculator on the hub shows that working in real time, and the mg ↔ units converter flips it back the other way for people who think in milligrams. The Reconstitution calculator answers the day-one question (how much bacteriostatic water to add and what concentration that gives), and the Vial Duration calculator answers the planning question (how many weeks one vial covers).

For this 5 mg TB-500 vial, the example numbers imply about 2 doses per vial and roughly 1.3 weeks of coverage at 2 doses per week — that's the math the Vial Duration tool exposes, and it's the number most people use to decide when to reorder. Every calculator on the hub uses these same five inputs (vial mg, diluent mL, dose, doses-per-week, syringe type), so changing your real numbers in one tool gives consistent answers across the others.

Logs documenting TB-500 administration most often show a subcutaneous cadence of once or twice per week, a pattern consistent with a molecule expected to have a prolonged duration of action. Some experimental designs incorporate an initial loading phase, where administration might occur several times per week for one to four weeks, before transitioning to a less frequent maintenance schedule. Due to the milligram-scale doses, a 1mL or 0.5mL U-100 insulin syringe is typically used to accurately draw the calculated volume from the reconstituted vial. Rotation of injection sites is a standard practice recorded in detailed logs to monitor for any localized skin reactions.

When planned in conjunction with a peptide requiring daily administration, like BPC-157, TB-500 is scheduled on its own rhythm within the week. A tracker might record daily BPC-157 entries while logging TB-500 doses only on Mondays and Thursdays, for example. This separation ensures that each protocol can be monitored independently without complex timing interactions. The precise time of day for a TB-500 dose is often considered less critical than for short-acting peptides, as the goal is to maintain a stable systemic concentration over many days rather than targeting a narrow post-injection activity window.